☆ 4.6 Article

Systemic immunosuppression depletes peripheral blood regulatory B cells in patients with immune thrombocytopenia

BRITISH JOURNAL OF HAEMATOLOGY (2023)

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Mycophenolate Mofetil for First-Line Treatment of Immune Thrombocytopenia

Charlotte A. Bradbury et al.

Summary: In a multicenter, open-label, randomized trial on patients with immune thrombocytopenia, 91.5% of patients who received mycophenolate mofetil plus glucocorticoids had platelet levels above 100,000 per microliter, compared to 63.9% of patients who received glucocorticoids only. Quality-of-life measures of physical function and fatigue were worse in the mycophenolate mofetil group.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection
Review Hematology

Thrombopoietin receptor agonists: ten years later

Waleed Ghanima et al.

HAEMATOLOGICA (2019)

Add to Collection
Review Immunology

Challenges and Opportunities for Consistent Classification of Human B Cell and Plasma Cell Populations

Ignacio Sanz et al.

FRONTIERS IN IMMUNOLOGY (2019)

Add to Collection
Review Hematology

Updated international consensus report on the investigation and management of primary immune thrombocytopenia

Drew Provan et al.

BLOOD ADVANCES (2019)

Add to Collection
Article Clinical Neurology

Regulatory B cells in myasthenia gravis are differentially affected by therapies

Vuslat Yilmaz et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2018)

Add to Collection
Article Immunology

The immune balance between memory and regulatory B cells in NMO and the changes of the balance after methylprednisolone or rituximab therapy

Chao Quan et al.

JOURNAL OF NEUROIMMUNOLOGY (2015)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.